David Newman - CardioComm Solutions Independent Director

EKGGF Stock  USD 0.01  0.00  0.00%   

Director

Dr. David Newman is Independent Director of the Company. He is an Associate Professor in the faculty of medicine at the University of Toronto. He received his medical training at Dalhousie University and the University of Toronto, followed by postdoctoral training at the University of California San Francisco and Stanford University. He is a recognized in the field of cardiac arrhythmias and their management and has experience with outpatient cardiac recording devices and their uses. since 2010.
Tenure 14 years
Professional MarksPh.D
Phone416 977 9425
Webhttps://www.cardiocommsolutions.com

CardioComm Solutions Management Efficiency

The company has return on total asset (ROA) of 0.164 % which means that it generated a profit of $0.164 on every $100 spent on assets. This is way below average. CardioComm Solutions' management efficiency ratios could be used to measure how well CardioComm Solutions manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 413.81 K in total debt with debt to equity ratio (D/E) of 430.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CardioComm Solutions has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CardioComm Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, CardioComm Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CardioComm Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CardioComm to invest in growth at high rates of return. When we think about CardioComm Solutions' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Alfred NovakLivaNova PLC
70
Pamela BaileyInteger Holdings Corp
72
Martin MaxwellInteger Holdings Corp
62
Steven WheelerAnika Therapeutics
70
Marie InfanteOrthopediatrics Corp
68
James HinrichsInteger Holdings Corp
53
Alvin JeffersInteger Holdings Corp
47
Bryan HughesOrthopediatrics Corp
40
William EcklesElectromed
42
John SicardOrthofix Medical
54
Alexis LukianovOrthofix Medical
61
David PelizzonOrthopediatrics Corp
62
Anthony MartinOrthofix Medical
59
Peter MunsonOrthopediatrics Corp
49
Cheryl BlanchardAnika Therapeutics
60
Jean HobbyInteger Holdings Corp
60
James HinrichsOrthofix Medical
50
Sharon OKaneLivaNova PLC
49
Alan KozlowskiOrthopediatrics Corp
51
Lisa HeineSurModics
54
Samuel RiccitelliOrthopediatrics Corp
59
CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada. Cardiocom Solutions operates under Health Information Services classification in the United States and is traded on OTC Exchange. CardioComm Solutions [EKGGF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

CardioComm Solutions Leadership Team

Elected by the shareholders, the CardioComm Solutions' board of directors comprises two types of representatives: CardioComm Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CardioComm. The board's role is to monitor CardioComm Solutions' management team and ensure that shareholders' interests are well served. CardioComm Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CardioComm Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
Etienne Grima, CEO, Corporate Secretary, Director and Member of Audit Committee
William Smith, Independent Director
Robert Caines, Director
Yury Levin, Independent Director
Anne Burpee, CFO
David Newman, Independent Director
Simi Grosman, Director
Anatoly Langer, Chairman of the Board
John Overall, CFO
Margaret Helms, Director
Josee CPA, Chief Officer
Steven Benyo, Director
MSc CHE, Corp CEO
Simi MBA, Independent Director
John Foote, Director
Wendy Hsieh, CFO

CardioComm Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CardioComm Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with CardioComm Solutions

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CardioComm Solutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CardioComm Solutions will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to CardioComm Solutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CardioComm Solutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CardioComm Solutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CardioComm Solutions to buy it.
The correlation of CardioComm Solutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CardioComm Solutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CardioComm Solutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CardioComm Solutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in CardioComm Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the CardioComm Solutions information on this page should be used as a complementary analysis to other CardioComm Solutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for CardioComm Pink Sheet analysis

When running CardioComm Solutions' price analysis, check to measure CardioComm Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CardioComm Solutions is operating at the current time. Most of CardioComm Solutions' value examination focuses on studying past and present price action to predict the probability of CardioComm Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CardioComm Solutions' price. Additionally, you may evaluate how the addition of CardioComm Solutions to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Valuation
Check real value of public entities based on technical and fundamental data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Please note, there is a significant difference between CardioComm Solutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if CardioComm Solutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CardioComm Solutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.